Evanthia T. Roussos Torres

Also affiliated with LAC+USC Medical Center, Keck Hospital of USC, California Southern University, USC Norris Comprehensive Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.2Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101511

Top 17%

1.2DataRank

Top 17%66 citations

Kaitlyn Saunders, Shao-Po Huang, Hildur Knútsdóttir, Kenneth Martinez-Algarin, Isabella Terrazas +9 more

Papers

Driven by 24 papers — median percentile 83. Top paper: “Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial”.

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03267-1

N/A

1.4DataRank · unranked

43 citations

Meghna S. Trivedi, Christina Yau, Rita Nanda, Hope S. Rugo, Marie Davidian +55 more

A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101511

Top 17%

1.2DataRank

Top 17%66 citations

Kaitlyn Saunders, Shao-Po Huang, Hildur Knútsdóttir, Kenneth Martinez-Algarin, Isabella Terrazas +9 more

Hypoxic Memory Mediates Prolonged Tumor-Intrinsic Type I Interferon Suppression to Promote Breast Cancer Progression

Cancer Research(2024)10.1158/0008-5472.can-23-2028

N/A

0.853DataRank · unranked

16 citations

Desirea Mecenas, Yilin Li, Christopher R. Chin, Amal Thomas, Aidan Moriarty +16 more

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03266-2

N/A

0.610DataRank · unranked

13 citations

Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian +52 more

Analysis of immune checkpoint blockade biomarkers in elderly patients using large-scale cancer genomics data.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2543

N/A

0DataRank · unranked

3 citations

Zheyu Wang, Sharon Wu, Joanne Xiu, Neeha Zaidi, Marc E. Lippman +12 more

Molecular characterization of the Ras-MAPK pathway in metastatic breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1034

N/A

0DataRank · unranked

2 citations

Jun Yin, Joanne Xiu, W. Michael Korn, Heinz‐Josef Lenz, Gino K. In +14 more

Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0170

N/A

0DataRank · unranked

62 citations

Christine I. Rafie, Julie K. Jang, Sofi Castanon, Aaron G. Baugh, Edgar Gonzalez +21 more

Hypoxic memory of tumor intrinsic type I interferon suppression promotes breast cancer metastasis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.12.491632

N/A

0DataRank · unranked

1 citations

Desirea Mecenas, Yilin Li, Christopher R. Chin, Amal Thomas, Yonatan Amzaleg +13 more

Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions

Oncogene(2023)10.1038/s41388-022-02584-4

N/A

0DataRank · unranked

56 citations

Francesca Battaglin, Carly Strelez, Annika Lenz, Sandra Algaze, Shivani Soni +12 more

Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche

Cancer Immunology Research(2023)10.1158/2326-6066.cir-22-0617

N/A

0DataRank · unranked

43 citations

Evanthia T. Roussos Torres, Adam L. MacLean, Jesse Kreger

Streamlining regulatory review in a multicenter platform trial: Opportunity to enhance patient centered care and drive innovation and efficiency.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1572

N/A

0DataRank · unranked

1 citations

Teresa Helsten, Brian Moore, Linda Neuhauser, Barbara LeStage, Paolo Castillo +12 more

Data from Differential Enhancement of Breast Cancer Cell Motility and Metastasis by Helical and Kinase Domain Mutations of Class IA Phosphoinositide 3-Kinase

(2023)10.1158/0008-5472.c.6500307

N/A

0DataRank · unranked

0 citations

Rory Flinn, Antonia Patsialou, Jeffrey Wyckoff, Evanthia T. Roussos Torres, Haiyan Wu +7 more

Data from Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche

(2023)10.1158/2326-6066.c.6573749.v1

N/A

0DataRank · unranked

0 citations

Evanthia T. Roussos Torres, Adam L. MacLean, Jesse Kreger

Data from Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche

(2023)10.1158/2326-6066.c.6573749

N/A

0DataRank · unranked

0 citations

Evanthia T. Roussos Torres, Adam L. MacLean, Jesse Kreger

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial

Nature Cancer(2024)10.1038/s43018-024-00729-w

N/A

0DataRank · unranked

47 citations

Won Jin Ho, Ludmila Danilova, Joseph A. Tandurella, James M. Leatherman, Christine I. Rafie +22 more

CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007939

N/A

0DataRank · unranked

15 citations

Yasmine Baca, Joshua Millstein, Yan Yang, Joanne Xiu, Hiroyuki Arai +24 more

Targeting circadian transcriptional programs through a cis-regulatory mechanism in triple negative breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.26.590360

N/A

0DataRank · unranked

1 citations

Tsu-Pei Chiu, Lili Zhou, Priscilla Chan, Tia Tyrsett Kuo, Francesca Battaglin +9 more

Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2 + breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.25.577282

N/A

0DataRank · unranked

0 citations

Edgar R. Gonzalez, Valerie H. Narumi, Jesse Kreger, Yingtong Liu, Christine I. Rafie +12 more

Modeling the dynamics of EMT reveals genes associated with pan-cancer intermediate states and plasticity

npj Systems Biology and Applications(2025)10.1038/s41540-025-00512-2

N/A

0DataRank · unranked

13 citations

R.B. Mehta, Evanthia T. Roussos Torres, Adam L. MacLean, MeiLu McDermott

Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors

Frontiers in Bioengineering and Biotechnology(2020)10.3389/fbioe.2020.00141

N/A

0DataRank · unranked

52 citations

Richard J. Sové, Mohammad Jafarnejad, Sondra Rahmeh, Elizabeth M. Jaffee, Vered Stearns +4 more

Interferon signaling and outcomes in triple-negative breast cancer (TNBC) in FinXX, CALGB 40603 (Alliance) and real-world clinico-genomic data.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.569

N/A

0DataRank · unranked

0 citations

Yi Liu, Sachin Kumar Deshmukh, Jodi M. Carter, Heikki Joensuu, Roberto A. Leon‐Ferre +15 more

Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide

OncoImmunology(2020)10.1080/2162402x.2020.1760685

N/A

0DataRank · unranked

20 citations

Akash Patil, Christine I. Rafie, Brian J. Christmas, Niranjan B. Pandey, Vered Stearns +4 more

Evaluating the impact of age on immune checkpoint therapy biomarkers

Cell Reports(2021)10.1016/j.celrep.2021.109599

N/A

0DataRank · unranked

80 citations

Zheyu Wang, Sharon Wu, Joanne Xiu, Neeha Zaidi, Jennifer La +20 more

Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-5017

N/A

0DataRank · unranked

35 citations

Christine I. Rafie, Chenguang Wang, David Lim, Adam Brufsky, Patricia LoRusso +16 more

Evanthia T. Roussos Torres

Indexed papers

Top data-sharing exemplar

Papers